RARITAN, N.J., Sept. 17Â -- The U.S. Food and Drug Administration (FDA) has approved use of the five-day, once-daily regimen of LEVAQUIN(R) (levofloxacin) 750 mg I.V. and oral, for the treatment of ...
The U.S. Food and Drug Administration today approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older. Levofloxacin ...
COLUMBUS, GA (WTVM) - In a News Leader 9 investigation—a antibiotic known by the brand name of ‘Levaquin’ is garnering national attention by medical researchers and doctors. Dr. Charles Bennett, who ...
Jan. 19, 2005 — The U.S. Food and Drug Administration (FDA) approved last October revisions to safety labeling to advise healthcare professionals of the following changes: ramipril may be linked to ...
FDA Extends Marketing Exclusivity for LEVAQUIN RARITAN, N.J., March 14 -- The U.S. Food and Drug Administration (FDA) has granted LEVAQUIN(R) (levofloxacin) an additional six months of marketing ...
June 21, 2011 — The US Food and Drug Administration (FDA) yesterday approved applications from 12 companies to manufacture generic versions of levofloxacin (Levaquin, Ortho-McNeil-Janssen ...
Please provide your email address to receive an email when new articles are posted on . Two phase 3 trials showed levofloxacin reduces the risk for multidrug-resistant TB after household exposure.
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR ROACH: I’m writing in to warn readers of a possible side effect of ...
Ripley County, MO (KFVS) - Remembering the good times. That’s what the Whiteside family is focusing on these days. “Her life was all about love and teaching us how to love others,” said Keith ...
SILVER SPRING, Md. — The Food and Drug Administration Tuesday approved the first generic versions of an antibiotic designed to treat certain infections in people ages 18 years and older. Generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results